Potential Nutraceuticals for COVID-19

References

• Astuti I, Ysrafil Y. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response. Diabetes Metab Syndr Clin Res Rev. 2020;14(4):407–412. doi:10.1016/j.dsx.2020.04.020
   PubMed Web of Science ®Google Scholar
• Rabaan AA, Al-Ahmed SH, Haque S, et al. SARS-CoV-2, SARS-CoV, and MERS-CoV: a comparative overview. Le Infez Med. 2020;2:174–184. doi:10.3366/edinburgh/9780748632909.003.0011
   Google Scholar
• Zhang X, Tan Y, Ling Y, et al. Viral and host factors related to the clinical outcome of COVID-19. Nature. 2020;583(7816):437–440. doi:10.1038/s41586-020-2355-0
   PubMed Web of Science ®Google Scholar
• Huang Y, Yang C, Xu X. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin. 2020;41(9):1141–1149. doi:10.1038/s41401-020-0485-4
   PubMed Web of Science ®Google Scholar
• Xiao L, Sakagami H, Miwa N. ACE2: the key molecule for understanding the pathophysiology of severe and critical conditions of COVID-19: demon or angel? Viruses. 2020;12(5):2002–2003. doi:10.3390/v12050491
   Web of Science ®Google Scholar
• Bestle D, Heindl MR, Limburg H, et al. TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets. bioRxiv. 2020. doi:10.1101/2020.04.15.042085
   Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8. doi:10.1016/j.cell.2020.02.052
   Web of Science ®Google Scholar
• Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–423. doi:10.1002/jmv.25681
   PubMed Web of Science ®Google Scholar
• Farshi P, Kaya EC, Hashempour-Baltork F, Khosravi-Darani K. A comprehensive review on the effect of plant metabolites on coronaviruses: focusing on their molecular docking score and IC50 values. Preprints. 2020. doi:10.20944/preprints202005.0295.v1
   Google Scholar
• Suravajhala R, Parashar A, Malik B, et al. Comparative docking studies on curcumin with COVID-19 proteins. Preprints. 2020;19:1–37. doi:10.20944/preprints202005.0439.v3
   Google Scholar
• Yi L, Li Z, Yuan K, et al. Small molecules blocking the entry of Severe Acute Respiratory Syndrome Coronavirus into host cells. J Virol. 2004;78(20):11334–11339. doi:10.1128/jvi.78.20.11334-11339.2004
   PubMed Web of Science ®Google Scholar
• Lin SC, Ho CT, Chuo WH, Li S, Wang TT, Lin CC. Effective inhibition of MERS-CoV infection by resveratrol. BMC Infect Dis. 2017;17(1):1–10. doi:10.1186/s12879-017-2253-8
   PubMed Web of Science ®Google Scholar
• Joshi RS, Jagdale SS, Bansode SB, et al. Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. J Biomol Struct Dyn. 2020;(May). doi:10.1080/07391102.2020.1760137
   Google Scholar
• Nguyen TTH, Woo HJ, Kang HK, et al. Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. Biotechnol Lett. 2012;34(5):831–838. doi:10.1007/s10529-011-0845-8
   PubMed Web of Science ®Google Scholar
• Lin CW, Tsai FJ, Tsai CH, et al. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res. 2005;68(1):36–42. doi:10.1016/j.antiviral.2005.07.002
   PubMed Web of Science ®Google Scholar
• Glinsky GV. Tripartite combination of potential pandemic mitigation agents: vitamin D, Quercetin, and Estradiol manifest properties of candidate medicinal agents for mitigation of the severity of pandemic COVID-19 defined by genomics-guided tracing of SARS-CoV-2 targ. Biomedicines. 2020;8(5):129.
   PubMed Web of Science ®Google Scholar
• Abian O, Ortega-Alarcon D, Jimenez-Alesanco A, et al. Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening. Int J Biol Macromol. 2020;164. doi:10.1016/j.ijbiomac.2020.07.235
   Web of Science ®Google Scholar
• Nabirotchkin S, Peluffo AE, Bouaziz J, Cohen D. Focusing on the unfolded protein response and autophagy related pathways to reposition common approved drugs against COVID-19. Preprints. 2020.
   Google Scholar
• Khan MF, Khan MA, Khan ZA, Ahamad T, Ansari WA. Identification of dietary molecules as therapeutic agents to combat COVID-19 using molecular docking studies. Research Square. 2020. doi:10.21203/rs.3.rs-19560/v1
   Google Scholar
• Umesh U, Kundu D, Selvaraj C, Singh SK, Dubey VK. Identification of new anti-nCoV drug chemical compounds from indian spices exploiting SARS-CoV-2 main protease as target. J Biomol Struct Dyn. 2020. doi:10.1080/07391102.2020.1763202
   Web of Science ®Google Scholar
• Bosch-Barrera J, Martin-Castillo B, Buxó M, Brunet J, Encinar JA, Menendez JA. Silibinin and SARS-CoV-2: dual targeting of host cytokine storm and virus replication machinery for clinical management of COVID-19 patients. J Clin Med. 2020;9(6):1770. doi:10.3390/jcm9061770
   PubMed Web of Science ®Google Scholar
• Hu X, Cai X, Song X, et al. Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor. Future Virol. 2020;15(6):359–368. doi:10.2217/fvl-2020-0099
   Web of Science ®Google Scholar
• Kar P, Kumar V, Vellingiri B, et al. Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation. J Biomol Struct Dyn. 2020. doi:10.1080/07391102.2020.01860133
   Web of Science ®Google Scholar
• Kar P, Sharma NR, Singh B, Sen A, Roy A. Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: an in silico investigation. J Biomol Struct Dyn. 2020;1–12. doi:10.1080/07391102.2020.1780947
   Web of Science ®Google Scholar
• Fischer A, Sellner M, Neranjan S, Smieško M, Lill MA. Potential inhibitors for novel coronavirus protease identified by virtual screening of 606 million compounds. Int J Mol Sci. 2020;21(10):1–17. doi:10.3390/ijms21103626
   Web of Science ®Google Scholar
• Das G, Das T, Chowdhury N, Chatterjee D, Bagchi A, Ghosh Z. Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19. Genomics. 2020. doi:10.1016/j.ygeno.2020.11.009
   Web of Science ®Google Scholar
• Meyer M, Jaspers I. Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants. fischer. 2015;308(12):1189–1201. doi:10.1152/ajplung.00028.2015
   Google Scholar
• Vonder Haar C, Peterson TC, Martens KM, Hoane MR. Vitamins and nutrients as primary treatments in experimental brain injury: clinical implications for nutraceutical therapies. Brain Res. 2016;1640:114–129. doi:10.1016/j.brainres.2015.12.030
   Web of Science ®Google Scholar
• Olthof MR, Hollman PC, Zock PL, Katan MB. Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. Am J Clin Nutr. 2001;73:3. doi:10.1093/ajcn/73.3.532
   Web of Science ®Google Scholar
• Fear G, Komarnytsky S, Raskin I. Protease inhibitors and their peptidomimetic derivatives as potential drugs. Pharmacol Ther. 2007;113(2):354–368. doi:10.1016/j.pharmthera.2006.09.001
   Web of Science ®Google Scholar
• Sabotič J, Kos J. Microbial and fungal protease inhibitors—current and potential applications. Appl Microbiol Biotechnol. 2012;93:1351–1375. doi:10.1007/s00253-011-3834-x
   PubMed Web of Science ®Google Scholar
• van de Ven WJM, Voorberg J, Fontijn R, et al. Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes. Mol Biol Rep. 1990;14(4):265–275. doi:10.1007/BF00429896
   PubMed Web of Science ®Google Scholar
• Deng X, StJohn SE, Osswald HL, et al. Coronaviruses resistant to a 3C-Like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistance. J Virol. 2014;88(20):11886–11898. doi:10.1128/jvi.01528-14
   PubMed Web of Science ®Google Scholar
• Hellinger R, Gruber CW. Peptide-based protease inhibitors from plants. Drug Discov Today. 2019;24(9):1877–1889. doi:10.1016/j.drudis.2019.05.026
   PubMed Web of Science ®Google Scholar
• Srikanth S, Chen Z. Plant protease inhibitors in therapeutics-focus on cancer therapy. Front Pharmacol. 2016;7:470. doi:10.3389/fphar.2016.00470
   PubMed Web of Science ®Google Scholar
• Lega S, Naviglio S, Volpi S, Tommasini A. Recent insight into SARS-COV2 immunopathology and rationale for potential treatment and preventive strategies in COVID-19. Vaccines. 2020;8(2):1–30. doi:10.3390/vaccines8020224
   Web of Science ®Google Scholar
• Azkur AK, Akdis M, Azkur D, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy Eur J Allergy Clin Immunol. 2020;75(7):1564–1581. doi:10.1111/all.14364
   Web of Science ®Google Scholar
• Oh HLJ, Gan SKE, Bertoletti A, Tan YJ. Understanding the T cell immune response in SARS coronavirus infection. Emerg Microbes Infect. 2012;1:23. doi:10.1038/emi.2012.26
   Web of Science ®Google Scholar
• Pedersen SF, Ho YC. SARS-CoV-2: A storm is raging. J Clin Invest. 2020;130(5):2202–2205. doi:10.1172/JCI137647
   PubMed Web of Science ®Google Scholar
• Yuen KS, Ye ZW, Fung SY, Chan CP, Jin DY. SARS-CoV-2 and COVID-19: the most important research questions. Cell Biosci. 2020;10(1):1–5. doi:10.1186/s13578-020-00404-4
   PubMed Web of Science ®Google Scholar
• Mizutani T. Signal transduction in SARS-CoV-infected cells. Ann N Y Acad Sci. 2007;1102:86–95. doi:10.1196/annals.1408.006
   PubMed Web of Science ®Google Scholar
• Pineau N, Aucouturier P, Brugier JC, Preud’homme JL. Jacalin: A lectin mitogenic for human CD4 T lymphocytes. Clin Exp Immunol. 1990;80(3):420–425. doi:10.1111/j.1365-2249.1990.tb03304.x
   Web of Science ®Google Scholar
• Al Mijan M, Lim BO. Diets, functional foods, and nutraceuticals as alternative therapies for inflammatory bowel disease: present status and future trends. World J Gastroenterol. 2018;24(25):2673–2685. doi:10.3748/wjg.v24.i25.2673
   Web of Science ®Google Scholar
• Yang DJ, Liu SC, Chen YC, Hsu SH, Chang YP, Lin JT. Three pathways assess anti-inflammatory response of epicatechin with lipopolysaccharide-mediated macrophage RAW264.7 Cells. J Food Biochem. 2015;39(3):334–343. doi:10.1111/jfbc.12134
   Web of Science ®Google Scholar
• Khan F, Niaz K, Maqbool F, et al. Molecular targets underlying the anticancer effects of quercetin: an update. Nutrients. 2016;8(9):1–19. doi:10.3390/nu8090529
   Web of Science ®Google Scholar
• Choi JS, Choi YJ, Shin SY, et al. Dietary flavonoids differentially reduce oxidized LDL-induced apoptosis in human endothelial cells: role of MAPK- and JAK/STAT-signaling. J Nutr. 2008;138(6):983–990. doi:10.1093/jn/138.6.983
   Web of Science ®Google Scholar
• Hämäläinen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007;2007:1–10.
   Web of Science ®Google Scholar
• Hsu SC, Chung JG. Anticancer potential of emodin. Biomed. 2012;2(3):108–116. doi:10.1016/j.biomed.2012.03.003
   PubMedGoogle Scholar
• Kashyap D, Tuli HS, Sharma AK. Ursolic acid (UA): A metabolite with promising therapeutic potential. Life Sci. 2016;146:201–213. doi:10.1016/j.lfs.2016.01.017
   PubMed Web of Science ®Google Scholar
• Huang MT, Ghai G, Ho CT. Inflammatory Process and Molecular Targets for Anti- inflammatory Nutraceuticals. Compr Rev Food Sci Food Saf. 2004;3(1):127–139.
   Google Scholar
• Yanaka N, Koyama TA, Komatsu SI, Nakamura E, Kanda M, Kato N. Vitamin B6 suppresses NF-kappaB activation in LPS-stimulated mouse macrophages. Int J Mol Med. 2005;16(6):1071–1075. doi:10.3892/ijmm.16.6.1071
   Web of Science ®Google Scholar
• Zhang L, Fan Y, Su H, et al. Chlorogenic acid methyl ester exerts strong anti-inflammatory effects: via inhibiting the COX-2/NLRP3/NF-κB pathway. Food Funct. 2018;9(12):6155–6164. doi:10.1039/c8fo01281d
   PubMed Web of Science ®Google Scholar
• Dos Tramontin N, Luciano TF, de OMarques S, de Souza CT, Muller AP. Ginger and avocado as nutraceuticals for obesity and its comorbidities. Phytother Res. 2020;34(6):1282–1290. doi:10.1002/ptr.6619
   Web of Science ®Google Scholar
• Majdalawieh AF, Mansour ZR. Sesamol, a major lignan in sesame seeds (Sesamum indicum): anti-cancer properties and mechanisms of action. Eur J Pharmacol. 2019;855:75–89. doi:10.1016/j.ejphar.2019.05.008
   PubMed Web of Science ®Google Scholar
• Sánchez‐sánchez MA, Zepeda‐morales ASM, Carrera‐quintanar L, et al. Alliin, an Allium sativum nutraceutical, reduces metaflammation markers in DIO mice. Nutrients. 2020;12(3). doi:10.3390/nu12030624
   Web of Science ®Google Scholar
• Nicholas C, Batra S, Vargo MA, et al. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-κB through the suppression of p65 phosphorylation. J Immunol. 2007;179(10):7121–7127. doi:10.4049/jimmunol.179.10.7121
   PubMed Web of Science ®Google Scholar
• Haghighatdoost F, Jabbari M, Hariri M. The effect of L-carnitine on inflammatory mediators: a systematic review and meta-analysis of randomized clinical trials. Eur J Clin Pharmacol. 2019. doi:10.1024/0300-9831/a000619
   Web of Science ®Google Scholar
• Marín-Aguilar F, Pavillard LE, Giampieri F, Bullón P, Cordero MD. Adenosine monophosphate (AMP)-activated protein kinase: A new target for nutraceutical compounds. Int J Mol Sci. 2017;18:2. doi:10.3390/ijms18020288
   Web of Science ®Google Scholar
• Sunil C, Xu B. An insight into the health-promoting effects of taxifolin (dihydroquercetin). Phytochemistry. 2019;166(July):112066. doi:10.1016/j.phytochem.2019.112066
   Google Scholar
• Zaki N, Alashwal H, Ibrahim S. Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review. Diabetes Metab Syndr Clin Res Rev. 2020;14(5):1133–1142. doi:10.1016/j.dsx.2020.07.005
   PubMed Web of Science ®Google Scholar
• Kim MS, Lee MS, Kown DY. Inflammation-mediated obesity and insulin resistance as targets for nutraceuticals. Ann N Y Acad Sci. 2011;1229(1):140–146. doi:10.1111/j.1749-6632.2011.06098.x
   Google Scholar
• Kahn BB, Flier JS, Kahn BB, Flier JS. Obesity and insulin resistance find the latest version: obesity and insulin resistance. J Clin Invest. 2000;106(4):473–481.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr. 2010;30:173–199. doi:10.1146/annurev.nutr.012809.104755
   PubMed Web of Science ®Google Scholar
• Ayres JS. A metabolic handbook for the COVID-19 pandemic. Nat Metab. 2020;2(7):572–585. doi:10.1038/s42255-020-0237-2
   PubMedGoogle Scholar
• Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr Clin Res Rev. 2020;14(4):303–310. doi:10.1016/j.dsx.2020.04.004
   PubMed Web of Science ®Google Scholar
• Rebello CJ, Kirwan JP, Greenway FL. Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link? Int J Obes. 2020;44(9):1810–1817. doi:10.1038/s41366-020-0640-5
   Web of Science ®Google Scholar
• Chen G, Wang H, Zhang X, Yang ST. Nutraceuticals and functional foods in the management of hyperlipidemia. Crit Rev Food Sci Nutr. 2014;54(9):1180–1201. doi:10.1080/10408398.2011.629354
   PubMed Web of Science ®Google Scholar
• Sorokin AV, Karathanasis SK, Yang ZH, Freeman L, Kotani K, Remaley AT. COVID-19—Associated dyslipidemia: implications for mechanism of impaired resolution and novel therapeutic approaches. FASEB J. 2020;34(8):9843–9853. doi:10.1096/fj.202001451
   PubMed Web of Science ®Google Scholar
• Houston M. The role of nutrition and nutraceutical supplements in the treatment of hypertension. World J Cardiol. 2014;6(2):38. doi:10.4330/wjc.v6.i2.38
   PubMedGoogle Scholar
• Chao CY, Yin MC, Huang CJ. Wild bitter gourd extract up-regulates mRNA expression of PPARα, PPARγ and their target genes in C57BL/6J mice. J Ethnopharmacol. 2011;135(1):156–161. doi:10.1016/j.jep.2011.03.001
   Web of Science ®Google Scholar
• Sridhar MG, Vinayagamoorthi R, Arul Suyambunathan V, Bobby Z, Selvaraj N. Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats. Br J Nutr. 2008;99(4):806–812. doi:10.1017/S000711450783176X
   Web of Science ®Google Scholar
• Misawa K, Hashizume K, Yamamoto M, Minegishi Y, Hase T, Shimotoyodome A. Ginger extract prevents high-fat diet-induced obesity in mice via activation of the peroxisome proliferator-activated receptor δ pathway. J Nutr Biochem. 2015;26(10):1058–1067. doi:10.1016/j.jnutbio.2015.04.014
   Web of Science ®Google Scholar
• Maharlouei N, Tabrizi R, Lankarani KB, et al. The effects of ginger intake on weight loss and metabolic profiles among overweight and obese subjects: A systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2019;59(11):1753–1766. doi:10.1080/10408398.2018.1427044
   PubMed Web of Science ®Google Scholar
• Shao W, Yu Z, Chiang Y, et al. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS One. 2012;7(1):1–13. doi:10.1371/journal.pone.0028784
   Web of Science ®Google Scholar
• Panahi Y, Khalili N, Sahebi E, et al. Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial. Complement Ther Med. 2017;33:1–5. doi:10.1016/j.ctim.2017.05.006
   PubMed Web of Science ®Google Scholar
• Lone J, Choi JH, Kim SW, Yun JW. Curcumin induces brown fat-like phenotype in 3T3-L1 and primary white adipocytes. J Nutr Biochem. 2016;27:193–202. doi:10.1016/j.jnutbio.2015.09.006
   PubMed Web of Science ®Google Scholar
• Yousaf S, Butt MS, Suleria HAR, Iqbal MJ. The role of green tea extract and powder in mitigating metabolic syndromes with special reference to hyperglycemia and hypercholesterolemia. Food Funct. 2014;5(3):545–556. doi:10.1039/c3fo60203f
   Web of Science ®Google Scholar
• Hsu SP, Wu MS, Yang CC, et al. Chronic green tea extract supplementation reduces hemodialysisenhanced production of hydrogen peroxide and hypochlorous acid, atherosclerotic factors, and proinflammatory cytokines. Am J Clin Nutr. 2007;86(5):1539–1547. doi:10.1093/ajcn/86.5.1539
   PubMed Web of Science ®Google Scholar
• Kang JH, Kim CS, Han IS, Kawada T, Yu R. Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages. FEBS Lett. 2007;581(23):4389–4396. doi:10.1016/j.febslet.2007.07.082
   PubMed Web of Science ®Google Scholar
• Jain PG, Patil SD, Haswani NG, Girase MV, Surana SJ. Atividade hipolipidemica de Moringa oleifera Lam., Moringaceae, na hiperlipidemia induzida por dieta rica em gordura em ratos albinos (Hypolipidemic activity of Moringa oleifera Lam., Moringaceae, on high fat diet induced hyperlipidemia in albino rats). Brazilian J Pharmacogn. 2010;20(6):969–973. doi:10.1590/S0102-695X2010005000038
   Google Scholar
• Kumari DJ. Hypoglycaemic effect of Moringa oleifera and Azadirachta indica in type 2 Diabetes mellitus. The Bioscan. 2010;5(2):211–214.
   Google Scholar
• Pipe EA, Gobert CP, Capes SE, Darlington GA, Lampe JW, Duncan AM. Soy protein reduces serum LDL cholesterol and the LDL cholesterol: HDL cholesterol and apolipoprotein B: apolipoproteinA-I ratios in adults with type 2 diabetes. J Nutr. 2009;139(9):1700–1706. doi:10.3945/jn.109.109595
   PubMed Web of Science ®Google Scholar
• Labban L, Mustafa UE-S, Ibrahim YM. The effects of Rosemary (Rosmarinus officinalis) leaves powder on glucose level, lipid profile and lipid perodoxation. Int J Clin Med. 2014;05(06):297–304. doi:10.4236/ijcm.2014.56044
   Google Scholar
• Esmaillzadeh A, Tahbaz F, Gaieni I, Alavi-Majd H, Azadbakht L. Cholesterol-lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia. Int J Vitam Nutr Res. 2006;76(3):147–151. doi:10.1024/0300-9831.76.3.147
   Web of Science ®Google Scholar
• Rock W, Rosenblat M, Miller-Lotan R, Levy AP, Elias M, Aviram M. Consumption of Wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities. J Agric Food Chem. 2008;56(18):8704–8713. doi:10.1021/jf801756x
   Web of Science ®Google Scholar
• Burton-Freeman B, Linares A, Hyson D, Kappagoda T. Strawberry modulates LDL oxidation and postprandial lipemia in response to high-fat meal in overweight hyperlipidemic men and women. J Am Coll Nutr. 2010;29(1):46–54. doi:10.1080/07315724.2010.10719816
   Web of Science ®Google Scholar
• Liu X, Xue Y, Liu C, et al. Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice. Lipids Health Dis. 2013;12(1):1–10. doi:10.1186/1476-511X-12-109
   Google Scholar
• Neschen S, Morino K, Dong J, et al. n-3 fatty acids preserve insulin sensitivity in vivoin a Peroxisome Proliferator – activated Receptor-α– dependent Manner. Diabetes. 2007;56(4):1034–1041. doi:10.2337/db06-1206.2-
   Web of Science ®Google Scholar
• Flachs P, Horakova O, Brauner P, et al. Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce β-oxidation in white fat. Diabetologia. 2005;48(11):2365–2375. doi:10.1007/s00125-005-1944-7
   PubMed Web of Science ®Google Scholar
• Levy BD, Kohli P, Gotlinger K, et al. Protectin D1 Is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol. 2010;178(1):496–502.
   Google Scholar
• Mickleborough TD, Tecklenburg SL, Montgomery GS, Lindley MR. Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells. Clin Nutr. 2009;28(1):71–77. doi:10.1016/j.clnu.2008.10.012
   PubMed Web of Science ®Google Scholar
• Farrell N, Norris G, Lee SG, Chun OK, Blesso CN. Anthocyanin-rich black elderberry extract improves markers of HDL function and reduces aortic cholesterol in hyperlipidemic mice. Food Funct. 2015;6(4):1278–1287. doi:10.1039/c4fo01036a
   Web of Science ®Google Scholar
• Li D, Zhang Y, Liu Y, Sun R, Xia M. Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients. J Nutr. 2015;145(4):742–748. doi:10.3945/jn.114.205674
   PubMed Web of Science ®Google Scholar
• Wolfram S, Raederstorff D, Preller M, et al. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr. 2006;136(10):2512–2518. doi:10.1093/jn/136.10.2512
   PubMed Web of Science ®Google Scholar
• Cremonini E, Bettaieb A, Haj FG, Fraga CG, Oteiza PI. -)-Epicatechin improves insulin sensitivity in high fat diet-fed mice. Arch Biochem Biophys. 2016;599:13–21. doi:10.1016/j.abb.2016.03.006
   PubMed Web of Science ®Google Scholar
• Moon J, Do HJ, Kim OY, Shin MJ. Antiobesity effects of quercetin-rich onion peel extract on the differentiation of 3T3-L1 preadipocytes and the adipogenesis in high fat-fed rats. Food Chem Toxicol. 2013;58:347–354. doi:10.1016/j.fct.2013.05.006
   PubMed Web of Science ®Google Scholar
• Lee SG, Parks JS, Kang HW. Quercetin, a functional compound of onion peel, remodels white adipocytes to brown-like adipocytes. J Nutr Biochem. 2017;42(2017):62–71. doi:10.1016/j.jnutbio.2016.12.018
   Google Scholar
• Gong M, Garige M, Varatharajalu R, et al. Quercetin up-regulates paraoxonase 1 gene expression with concomitant protection against LDL oxidation. Biochem Biophys Res Commun. 2009;379(4):1001–1004. doi:10.1016/j.bbrc.2009.01.015
   Web of Science ®Google Scholar
• Rivera L, Morón R, Sánchez M, Zarzuelo A, Galisteo M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity. 2008;16(9):2081–2087. doi:10.1038/oby.2008.315
   PubMed Web of Science ®Google Scholar
• Luo C, Yang H, Tang C, et al. Kaempferol alleviates insulin resistance via hepatic IKK/NF-κB signal in type 2 diabetic rats. Int Immunopharmacol. 2015;28(1):744–750. doi:10.1016/j.intimp.2015.07.018
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu D. Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function. Eur J Pharmacol. 2011;670(1):325–332. doi:10.1016/j.ejphar.2011.08.011
   PubMed Web of Science ®Google Scholar
• Goto T, Teraminami A, Lee J-Y, et al. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese–diabetic mice. J Nutr Biochem. 2012;23(7):768–776. doi:10.1016/j.jnutbio.2011.04.001
   PubMed Web of Science ®Google Scholar
• Priscilla DH, Jayakumar M, Thirumurugan K. Flavanone naringenin: an effective antihyperglycemic and antihyperlipidemic nutraceutical agent on high fat diet fed streptozotocin induced type 2 diabetic rats. J Funct Foods. 2015;14:363–373. doi:10.1016/j.jff.2015.02.005
   Web of Science ®Google Scholar
• Ahmed OM, Mahmoud AM, Abdel-Moneim A, Ashour MB. Antidiabetic effects of hesperidin and naringin in type 2 diabetic rats. Diabetol Croat. 2012;41(2):53–67.
   Google Scholar
• Liu Z, Liu T, Lei C, et al. Novel role of hesperidin improve obesity in HFD mice by modulating the composition of the gut microbiota. Res Sq. 2020. doi:10.21203/rs.2.21089/v1
   Google Scholar
• El-Bassossy HM, Abo-Warda SM, Fahmy A. Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: effect on lipid profile, AGEs and NO generation. Phytother Res. 2013;27(11):1678–1684. doi:10.1002/ptr.4917
   Web of Science ®Google Scholar
• El-Bassossy HM, Abo-Warda SM, Fahmy A. Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation. Am J Chin Med. 2014;42(5):1153–1167. doi:10.1142/S0192415X14500724
   PubMed Web of Science ®Google Scholar
• Zhang L, Han Y-J, Zhang X, et al. Luteolin reduces obesity-associated insulin resistance in mice by activating AMPKα1 signalling in adipose tissue macrophages. Diabetologia. 2016;59(10):2219–2228. doi:10.1007/s00125-016-4039-8
   PubMed Web of Science ®Google Scholar
• Fu Z, Liu D. Long-term exposure to genistein improves insulin secretory function of pancreatic β-cells. Eur J Pharmacol. 2009;616(1–3):321–327. doi:10.1016/j.ejphar.2009.06.005
   PubMed Web of Science ®Google Scholar
• Hsu CL, Wu CH, Huang SL, Yen GC. Phenolic compounds rutin and o-coumaric acid ameliorate obesity induced by high-fat Diet in rats. J Agric Food Chem. 2009;57(2):425–431. doi:10.1021/jf802715t
   PubMed Web of Science ®Google Scholar
• Abdel-Moneim A, SMA E-T, Yousef AI, Reheim ESA, Ashour MB. Modulation of hyperglycemia and dyslipidemia in experimental type 2 diabetes by gallic acid and p-coumaric acid: the role of adipocytokines and PPARγ. Biomed Pharmacother. 2018;105:1091–1097. doi:10.1016/j.biopha.2018.06.096
   PubMed Web of Science ®Google Scholar
• Ibitoye OB, Ajiboye TO. Dietary phenolic acids reverse insulin resistance, hyperglycaemia, dyslipidaemia, inflammation and oxidative stress in high-fructose diet-induced metabolic syndrome rats. Arch Physiol Biochem. 2018;124(5):410–417. doi:10.1080/13813455.2017.1415938
   PubMed Web of Science ®Google Scholar
• Antunes AEC, Vinderola G, Xavier-Santos D, Sivieri K. Potential contribution of beneficial microbes to face the COVID-19 pandemic. Food Res Int. 2020;136(June):109577. doi:10.1016/j.foodres.2020.109577
   Google Scholar
• Dhar D, Mohanty A. Gut microbiota and Covid-19- possible link and implications. Virus Res. 2020;285:198018. doi:10.1016/j.virusres.2020.198018
   PubMed Web of Science ®Google Scholar
• Berggren A, Lazou Ahrén I, Larsson N, Önning G. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr. 2011;50(3):203–210. doi:10.1007/s00394-010-0127-6
   PubMed Web of Science ®Google Scholar
• de Vrese M, Winkler P, Rautenberg P, et al. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine. 2006;24(44–46):6670–6674. doi:10.1016/j.vaccine.2006.05.048
   PubMed Web of Science ®Google Scholar
• Boge T, Rémigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R. van der Werf S. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine. 2009;27(41):5677–5684. doi:10.1016/j.vaccine.2009.06.094
   PubMed Web of Science ®Google Scholar
• National US. Library of Medicine. Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers. 2020. Available from: https://clinicaltrials.gov/ct2/show/NCT04366180. Accessed January 15, 2021.
   Google Scholar
• U.S. National Library of Medicine. Bacteriotherapy in the Treatment of COVID-19 (BACT-Ovid).. Https://Clinicaltrials.gov/Ct2/Show/Nct04368351. 2020. Available from:.
   Google Scholar
• Corrêa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MAR. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunol. 2016;5(4):1–8. doi:10.1038/cti.2016.17
   Web of Science ®Google Scholar
• Li M, BCAM VE, Wagenaar GTM, Garssen J, Folkerts G, Henricks PAJ. Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells. Eur J Pharmacol. 2018;831:52–59. doi:10.1016/j.ejphar.2018.05.003
   PubMed Web of Science ®Google Scholar
• Venkatakrishnan K, Chiu HF, Wang CK. An extensive review on popular functional foods and nutraceuticals against obesity and its related complications with a special focus on randomized clinical trials. Food Funct. 2019. doi:10.1039/C9FO00293F.Food
   Web of Science ®Google Scholar
• Chakrabarti S, Wu J. Milk-derived tripeptides IPP (Ile-Pro-Pro) and VPP (Val-Pro- Pro) promote adipocyte differentiation and inhibit inflammation in 3T3-F442A cells. PLoS One. 2015;10(2):1–15. doi:10.1371/journal.pone.0117492
   Web of Science ®Google Scholar
• Ortega-González M, Capitán-Cañadas F, Requena P, et al. Validation of bovine glycomacropeptide as an intestinal anti-inflammatory nutraceutical in the lymphocyte-transfer model of colitis. Br J Nutr. 2014;111(7):1202–1212. doi:10.1017/S0007114513003590
   Web of Science ®Google Scholar
• Nakamura T, Hirota T, Mizushima K, et al. Milk-derived peptides, Val-Pro-Pro and Ile-Pro-Pro, attenuate atherosclerosis development in apolipoprotein E-deficient mice: A preliminary study. J Med Food. 2013;16(5):396–403. doi:10.1089/jmf.2012.2541
   PubMed Web of Science ®Google Scholar
• Iskandar MM, Dauletbaev N, Kubow S, Mawji N, Lands LC. Whey protein hydrolysates decrease IL-8 secretion in lipopolysaccharide (LPS)-stimulated respiratory epithelial cells by affecting LPS binding to Toll-like receptor 4. Br J Nutr. 2013;110(1):58–68. doi:10.1017/S0007114512004655
   PubMed Web of Science ®Google Scholar
• Majumder K, Chakrabarti S, Davidge ST, Wu J. Structure and activity study of egg protein ovotransferrin derived peptides (IRW and IQW) on endothelial inflammatory response and oxidative stress. J Agric Food Chem. 2013;61(9):2120–2129. doi:10.1021/jf3046076
   Web of Science ®Google Scholar
• de Mejia EG, Dia VP. Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-κB pathway in the macrophage. Peptides. 2009;30(12):2388–2398. doi:10.1016/j.peptides.2009.08.005
   PubMed Web of Science ®Google Scholar
• Kovacs-Nolan J, Zhang H, Ibuki M, et al. The PepT1-transportable soy tripeptide VPY reduces intestinal inflammation. Biochim Biophys Acta - Gen Subj. 2012;1820(11):1753–1763. doi:10.1016/j.bbagen.2012.07.007
   PubMed Web of Science ®Google Scholar
• Bjørndal B, Berge C, Ramsvik MS, et al. A fish protein hydrolysate alters fatty acid composition in liver and adipose tissue and increases plasma carnitine levels in a mouse model of chronic inflammation. Lipids Health Dis. 2013;12(1):1–11. doi:10.1186/1476-511X-12-143
   PubMedGoogle Scholar
• Zhang Y, Kouguchi T, Shimizu K, Sato M, Takahata Y, Morimatsu F. Chicken collagen hydrolysate reduces proinflammatory cytokine production in C57BL/6.KOR-ApoEsh1 mice. J Nutr Sci Vitaminol (Tokyo). 2010;56(3):208–210. doi:10.3177/jnsv.56.208
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Asano M, Sato K, et al. Wheat gluten hydrolysate alters the progress of hepatic pathology induced by prolonged carbon tetrachloride administration in rat. Biomed Res. 2011;22(4):481–488.
   Google Scholar
• Hirai S, Horii S, Matsuzaki Y, et al. Anti-inflammatory effect of pyroglutamyl-leucine on lipopolysaccharide-stimulated RAW 264.7 macrophages. Life Sci. 2014;117(1):1–6. doi:10.1016/j.lfs.2014.08.017
   PubMed Web of Science ®Google Scholar
• Udechukwu MC, Tsopmo A, Mawhinney H, He R, Kienesberger PC, Udenigwe CC. Inhibition of ADAM17/TACE activity by zinc-chelating rye secalin-derived tripeptides and analogues. RSC Adv. 2017;7(42):26361–26369. doi:10.1039/c6ra26678a
   Web of Science ®Google Scholar
• RML CB, Berrill M, Marik PE. The antiviral properties of vitamin C. Expert Rev Anti Infect Ther. 2020;18:2. doi:10.1080/14787210.2020.1706483
   Web of Science ®Google Scholar
• Chiscano-Camón L, Ruiz-Rodriguez JC, Ruiz-Sanmartin A, Roca O, Vitamin FR. C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome. Crit Care. 2020;24:1. doi:10.1186/s13054-020-03249-y
   Google Scholar
• Feyaerts AF, Luyten W. Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19? Nutrition. 2020;110948:79–80. doi:10.1016/j.nut.2020.110948
   Google Scholar
• Hiedra R, Lo KB, Elbashabsheh M, et al. The Use of IV vitamin C for patients with COVID-19: a single center observational study. Expert Rev Anti Infect Ther. 2020;18(12):1259–1261. doi:10.1080/14787210.2020.1794819
   PubMed Web of Science ®Google Scholar
• RML CB, Berrill M, Catravas JD, Marik PE. Quercetin and Vitamin C: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19). Front Immunol. 2020. doi:10.3389/fimmu.2020.01451
   Web of Science ®Google Scholar
• Davis JM, Murphy EA, McClellan JL, Carmichael MD, Gangemi JD. Quercetin reduces susceptibility to influenza infection following stressful exercise. Am J Physiol - Regul Integr Comp Physiol. 2008;295(2):505–509. doi:10.1152/ajpregu.90319.2008
   PubMed Web of Science ®Google Scholar
• Arslan B, Ucuncu Ergun N, Topuz S, et al. Synergistic Effect of Quercetin and Vitamin C Against COVID-19: is a Possible Guard for Front Liners. SSRN Electron J. 2020. doi:10.2139/ssrn.3682517
   Google Scholar
• Grant WB, Lahore H, McDonnell SL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and covid-19 infections and deaths.. Nutrients. 2020;12(4):1–19. doi:10.3390/nu12040988
   Web of Science ®Google Scholar
• Arboleda JF, Urcuqui-Inchima S. Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. Front Immunol. 2020;11(1523):1–4. doi:10.1136/bmj.m641
   Google Scholar
• Ebadi M, Montano-Loza AJ. Perspective: improving vitamin D status in the management of COVID-19. Eur J Clin Nutr. 2020;74(6):856–859. doi:10.1038/s41430-020-0661-0
   PubMed Web of Science ®Google Scholar
• Ghavideldarestani M, Honardoost M, Khamseh ME. Role of Vitamin D in Pathogenesis and Severity of Coronavirus Disease 2019 (COVID-19) Infection. Pakistan J Med Heal Sci. 2020;14(2):462–465. doi:10.20944/preprints202004.0355.v1
   Web of Science ®Google Scholar
• U.S. National Library of Medicine. Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19; 2020. Available from: https://clinicaltrials.gov/ct2/show/NCT04421534. Accessed January 15, 2021.
   Google Scholar